ECSP993132A - HIV PROTEASE INHIBITORS - Google Patents
HIV PROTEASE INHIBITORSInfo
- Publication number
- ECSP993132A ECSP993132A ECSP993132A ECSP993132A EC SP993132 A ECSP993132 A EC SP993132A EC SP993132 A ECSP993132 A EC SP993132A EC SP993132 A ECSP993132 A EC SP993132A
- Authority
- EC
- Ecuador
- Prior art keywords
- protease inhibitors
- hiv protease
- dihydropyrones
- relates
- present
- Prior art date
Links
- 239000004030 hiv protease inhibitor Substances 0.000 title 1
- 208000030507 AIDS Diseases 0.000 abstract 1
- 102000004580 Aspartic Acid Proteases Human genes 0.000 abstract 1
- 108010017640 Aspartic Acid Proteases Proteins 0.000 abstract 1
- 208000036142 Viral infection Diseases 0.000 abstract 1
- 230000000903 blocking effect Effects 0.000 abstract 1
- 150000001875 compounds Chemical class 0.000 abstract 1
- 201000010099 disease Diseases 0.000 abstract 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 1
- 125000000623 heterocyclic group Chemical group 0.000 abstract 1
- 239000000543 intermediate Substances 0.000 abstract 1
- 238000000034 method Methods 0.000 abstract 1
- 230000000144 pharmacologic effect Effects 0.000 abstract 1
- 230000002194 synthesizing effect Effects 0.000 abstract 1
- 238000002560 therapeutic procedure Methods 0.000 abstract 1
- 230000009385 viral infection Effects 0.000 abstract 1
Landscapes
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
La presente invención se relaciona con dihidropironas novedosas con heterociclos unidos a ellas que tienen propiedades farmocológicas mejoradas que inhiben en forma potente la HIV aspartil proteasa bloqueando la infectividad del HIV. Las dihidroperonas son útiles en el desarrollo de terapias para el tratamiento de infecciones y enfermedades virales, incluyendo el SIDA. La presente invención se refiere también a los métodos de sintesis de las dihidropironas y los intermedios útiles en la preparación de los compuestos finales.The present invention relates to novel dihydropyrones with heterocycles attached to them that have improved pharmacological properties that potently inhibit HIV aspartyl protease by blocking HIV infectivity. Dihydroperones are useful in the development of therapies for the treatment of viral infections and diseases, including AIDS. The present invention also relates to methods of synthesizing dihydropyrones and intermediates useful in the preparation of the final compounds.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| ECSP993132 ECSP993132A (en) | 1999-09-10 | 1999-09-10 | HIV PROTEASE INHIBITORS |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| ECSP993132 ECSP993132A (en) | 1999-09-10 | 1999-09-10 | HIV PROTEASE INHIBITORS |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ECSP993132A true ECSP993132A (en) | 2000-05-25 |
Family
ID=42044120
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ECSP993132 ECSP993132A (en) | 1999-09-10 | 1999-09-10 | HIV PROTEASE INHIBITORS |
Country Status (1)
| Country | Link |
|---|---|
| EC (1) | ECSP993132A (en) |
-
1999
- 1999-09-10 EC ECSP993132 patent/ECSP993132A/en unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| MX2022001421A (en) | TETRACYCLIC COMPOUND, METHOD OF PREPARATION AND USE THEREOF. | |
| UY26886A1 (en) | POLYMORPHES OF AN EPOTILONE ANALOG | |
| EA201991693A1 (en) | PYRIDINE DERIVATIVE AS ASK1 INHIBITOR AND METHOD FOR PRODUCING AND USE | |
| PT1142887E (en) | 5,6-DIHYDROOPIRONE DERIVATIVES AS PROTEASE INHIBITORS AND ANTIVIRAL AGENTS | |
| EP4157272C0 (en) | Remdesivir for the treatment of viral infections | |
| EA201591702A1 (en) | COMBINATION OF TWO ANTI-VIRAL PREPARATIONS FOR THE TREATMENT OF HEPATITIS C | |
| ES2112880T3 (en) | HIV PROTEASE INHIBITORS USEFUL FOR AIDS TREATMENT. | |
| CR8273A (en) | ADMINISTRATION OF TLR7 LIGANDS AND PROFARMS OF THE SAME FOR THE TREATMENT OF INFECTION BY HEPETITIS C VIRUS | |
| BRPI0411900A (en) | antiviral compounds and methods | |
| CL2020002157A1 (en) | Triazine derivatives for the treatment of neurotrophin-related diseases. | |
| CU24525B1 (en) | QUINOLEIN DERIVATIVE TO TREAT AND PREVENT VIRAL INFECTIONS | |
| ES2188604T3 (en) | HIV PROTEASE INHIBITORS IN PHARMACEUTICAL COMBINATIONS FOR AIDS TREATMENT. | |
| MX2024010334A (en) | Pharmaceutical composition comprising anti-ctla4-anti-pd-1 bispecific antibody and chiauranib. | |
| EA201591701A1 (en) | COMBINATION OF ANTI-VIRAL DIRECT ACTION AND RIBAVIRIN FOR THE TREATMENT OF PATIENTS WITH HCV | |
| GEAP202014873A (en) | Methods for treatment and prophylaxis of hiv and aids | |
| ES2176263T3 (en) | 5,6-DIHYDROPIRONAS DERIVED AS PROTEASA INHIBITORS AND ANTIVIRUS AGENTS. | |
| BR0209645A (en) | Oxazole and furopyrimidines and their use as medicines | |
| ATE319473T1 (en) | MELAGATRAN FOR THE TREATMENT OF INFLAMMATION | |
| PA8451301A1 (en) | A NEW SALT | |
| EA201992233A1 (en) | COMPOUNDS OF ISOXOXOLICARBOXAMIDE AND THEIR APPLICATION | |
| EA202191001A1 (en) | COMPOUNDS FOR TREATMENT OF ARENAVIRAL INFECTION | |
| ECSP993132A (en) | HIV PROTEASE INHIBITORS | |
| WO2000015634A3 (en) | Hiv protease inhibitors | |
| CY1114254T1 (en) | Intravenous injection of non-neurotoxic plasminogen activators to treat cerebral episode | |
| ES2191035T3 (en) | DERIVATIVES OF PIRONA AS INHIBITORS OF PROTEASA AND ANTIVIRICAL AGENTS. |